Testing effectiveness (Phase 2)Ended earlyNCT03329248
What this trial is testing
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Who this might be right for
Pancreatic Cancer
ImmunityBio, Inc. 6